Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, talks on the importance of integrating advances in basic research into clinical trials for multiple myeloma and combining novel technologies together in order to provide personalized therapies to patients. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.